Vumerity is a next-generation oral fumarate treatment for adults with relapsing-remitting multiple sclerosis
News
NICE recommends Inrebic for rare blood cancer
Eligible adult patients with primary or secondary myelofibrosis will now be able to access the treatment on the NHS
NICE approves first long-acting jab for HIV to replace daily pills
The announcement follows a positive decision from the SMC in October 2021
Under-18s with COVID-19 in UK advised to wait 12 weeks for vaccine dose
The UKHSA have said that deferring the vaccine dose could help to reduce even further the small risk of heart inflammation following vaccination
European Commission approves Nucala treatment in three diseases
This marks the first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA)
New NHS stroke treatment drug agreement could save 5,000 a year
This deal will see more patients having access to treatment which could prevent 21,700 strokes and 5,400 deaths
Pfizer signs deal to allow expanded use of COVID-19 treatment
Voluntary license agreement will allow generic versions of pill to be manufactured
EC approves Celltrion’s COVID-19 mAb Regkirona
Treatment authorised for use in adults with COVID-19 who are at high-risk of progressing to severe disease
Report: UK disposed of 600,000 AZ vaccine doses after they passed expiry date
The data was obtained by a Freedom of Information request, according to The Independent
NICE recommends cenobamate for treatment of adult epilepsy patients in UK
Epilepsy affects over 600,000 people in the UK, which is approximately one in every 100 people
JCVI advises extending COVID-19 booster programme
All adults aged 40- to 49-years-old to be offered an mRNA vaccine booster dose
Vertex receives CHMP positive opinion for Kaftrio in children with cystic fibrosis
Those eligible will have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
NICE ‘no’ for BioMarin’s Vimizin
The draft guidance has been published following an evaluation of new evidence on the use of the treatment
New drug combination highly effective in children with leukaemia
APL is an acute leukaemia, meaning it develops quickly and requires immediate treatment
New COVID-19 vaccines could target replication proteins
Researchers have said that next generation vaccines for COVID-19 should aim to induce a response against ‘replication proteins’
